Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

3,4,5-Trimethoxy-trans-cinnamic acid

SKU: orb1218509

Description

3,4,5-Trimethoxy-trans-cinnamic acid is a natural product from the roots and rhizomes of Notopterygium incisum.

Images & Validation

−
3,4,5-Trimethoxy-trans-cinnamic acid

Key Properties

−
CAS Number20329-98-0
MW238.24
Purity>98% (HPLC)
FormulaC12H14O5
SMILESCOc1cc(/C=C/C(O)=O)cc(OC)c1OC
TargetOthers
SolubilityIn Vitro: DMSO : 100 mg/mL (419.74 mM)

Bioactivity

−
In Vivo
(E)-3, 4, 5-Trimethoxycinnamic acid (0-20 mg/kg, IP, once) shows anti-seizure effects. (E)-3, 4, 5-Trimethoxycinnamic acid (0-10 mg/kg, Orally, once) enhances hypnotic effects in pentobarbital-treated mice. Animal model: Ault male KunMing-strain mice (18-20 g, maximal electroshock (MES) and pentylenetetrazol (PTZ) models). Dosage: 5, 10 and 20 mg/kg; 10 mL/kg. Administration: IP, once. Result: Significantly decreased the incidence of MES-induced THE (tonic hindlimb extension) to 50% and 20% of the value of the vehicle controls at 10 and 20 mg/kg. Decreased the incidence of MES-induced THE to only 80% at 5 mg/kg. Significantly delayed the onset of myoclonic jerks (MJ), and decreased the seizure severity and mortality compared with the vehicle-treated animals in PTZ seizure model. The incidence of generalized clonic convulsions (stage 4) disappeared at doses of both 10 and 20 mg/kg. Animal model: ICR male mice (25-28 g, 10-12 in each group). Dosage: 2, 5 and 10 mg/kg. Administration: Orally (p.o.), once, 15 min and 1 h prior to pentobarbital injection. Result: Significantly decreased locomotor activity at 10 mg/kg. Increased NREM and total sleep, but decreased wakefulness.
In Vitro
(E)-3, 4, 5-Trimethoxycinnamic acid (10 μg/mL, 1 h) increases the expressions of GAD65 and γ-subunit of GABAA receptors in the cerebellar granule cells. (E)-3, 4, 5-Trimethoxycinnamic acid (0-10 μg/mL, 1 h) shows a significant increase in Cl- influx. Western blot analysis. Cell line: Primary cultured cerebellar granule cells. Concentration: 10 μg/mL. Incubation time: 1 h. Result: Increased expression of GAD65 (glutamic acid decarboxylase) and γ-subunit of GABAA receptors, but did not influence the amounts of a-, b-subunits in the GABAA receptors. Cell Viability Assay Cell line: Primary cultured cerebellar granule cells. Concentration: 1, 3, 5, 10 μg/mL. Incubation time: 1 h. Result: Produced a significant increase in Cl- influx.

Storage & Handling

−
StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
O-Methylsinapic acid | 3,4,5-Trimethoxyphenylacrylic acid

Similar Products

−
  • (E)-3,4,5-Trimethoxycinnamic acid

    (E)-3,4,5-Trimethoxycinnamic acid [orb1297136]

    99.83% (May vary between batches)

    20329-98-0

    238.2366

    C12H14O5

    1 ml x 10 mM (in DMSO), 1 g, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol
Others

Protocol Information

Find More Protocols

Available Sizes

Select a size below

200 mg
Enquire
1 g
Enquire
500 mg
Enquire
50 mg
$ 90.00
100 mg
$ 120.00
Bulk Enquiry
Need technical support? Find your Distributor Return and Tax Policy

Email

info@biorbyt.com

UK Office

+44 (0)1223 859353

US Office

+1 (415) 906-5211

CN Office

+86 (27)-87663101

Distributors

biorbyt.com/distributor